Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.64338 | 60 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.49659 | 58 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.51332 | 58 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.39932 | 57 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.4536 | 58 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.75545 | 62 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.778 | 62 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.51356 | 58 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.47527 | 58 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.47633 | 58 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.53526 | 59 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.43593 | 57 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.59433 | 60 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.54311 | 59 |